Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
Clinical trial NCT03155997 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03155997
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-12
- Primary completion
- 2020-03-16
- Enrollment
- 5637
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.